In a postmenopausal woman with a history of Cushing's disease, primary aldosteronism (Conn's syndrome), mild autonomous cortisol secretion (MACS), and adrenalectomy 10 weeks ago, are total testosterone of 232.86 ng/dL and free testosterone of 2.7 ng/dL dangerous, and what are the possible causes, symptoms, and recommended next steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Elevated Testosterone Post-Adrenalectomy: Urgent Evaluation Required

These testosterone levels (total 232.86 ng/dL, free 2.7 ng/dL) are markedly elevated for a postmenopausal woman and require immediate investigation for an androgen-secreting tumor, most likely of ovarian origin given your recent adrenalectomy. Normal postmenopausal testosterone is typically <50 ng/dL, and levels above 150 ng/dL mandate urgent workup for neoplasm 1.

Why This Is Dangerous

Your testosterone is approximately 4-5 times the upper limit of normal for postmenopausal women. This degree of elevation carries significant risks:

  • Tumor likelihood: Testosterone >150 ng/dL strongly suggests an androgen-secreting tumor rather than functional hyperandrogenism 1
  • Cardiovascular risk: Severe hyperandrogenism increases cardiovascular morbidity
  • Irreversible virilization: Voice deepening, clitoral enlargement, and male-pattern baldness may become permanent if untreated 2
  • Malignancy potential: While rare, some androgen-secreting tumors can be malignant

Most Likely Causes in Your Case

Given your post-adrenalectomy status (ruling out adrenal source), the differential is:

1. Ovarian Androgen-Secreting Tumor (Most Likely)

  • Adult granulosa cell tumor - accounts for 10% of ovarian tumors causing hyperandrogenism 2
  • Leydig cell tumor - can be small and difficult to detect on imaging 1
  • Ovarian hyperthecosis - less likely given the severity of elevation

2. Residual/Ectopic Adrenal Tissue (Less Likely)

  • Rare but possible after adrenalectomy
  • Your history of MACS and Cushing's makes this worth excluding

3. Exogenous Androgen Exposure

  • Verify no testosterone supplementation, DHEA supplements, or contaminated medications

Expected Symptoms to Monitor

You should assess yourself for these virilization signs:

Progressive symptoms:

  • Hirsutism (facial hair, chest, abdomen, back)
  • Male-pattern baldness (vertex/frontal)
  • Voice deepening (often irreversible)
  • Clitoral hypertrophy
  • Increased muscle mass
  • Acne, oily skin
  • Loss of female body contour

Metabolic effects:

  • Worsening hypertension
  • Insulin resistance/diabetes
  • Dyslipidemia 3

Neuropsychiatric:

  • Anxiety, depression, mood changes 3

Immediate Next Steps (Algorithmic Approach)

Step 1: Complete Hormonal Panel (Within 1 Week)

Order these specific tests:

  • DHEA-S: If >700 μg/dL, suggests adrenal source (residual tissue) 1
  • Androstenedione: Helps localize source
  • LH and FSH: Should be suppressed if tumor present 2
  • AMH (anti-Müllerian hormone): Low levels (<0.1 ng/mL) support granulosa cell tumor 2
  • SHBG: Usually low in hyperandrogenism 4
  • 17-hydroxyprogesterone: Rule out 21-hydroxylase deficiency 4

Interpretation algorithm:

  • If DHEA-S >700 μg/dL → Suspect residual/ectopic adrenal tissue
  • If DHEA-S normal + suppressed LH/FSH + low AMH → Ovarian tumor highly likely 2

Step 2: Imaging (Within 2 Weeks)

Critical: Do NOT rely on ultrasound alone - it missed the tumor in a recent case 2

  • Pelvic MRI with contrast (FIRST-LINE): Superior sensitivity for small ovarian tumors 2
  • CT abdomen/pelvis: Evaluate for residual adrenal tissue or ectopic adrenal rests
  • Look specifically for: enhancing adnexal nodules (even 2-3 cm can be significant) 2

Step 3: If Imaging Is Negative But Biochemistry Suggests Tumor

Proceed to selective ovarian vein catheterization 1:

  • This invasive test samples blood directly from ovarian veins
  • Compares testosterone levels between right and left ovaries
  • Essential when small tumors (<2 cm) evade imaging detection
  • Should be performed at specialized centers

Step 4: Surgical Planning

If ovarian tumor confirmed:

  • Bilateral salpingo-oophorectomy is recommended for postmenopausal women (you don't need ovarian preservation) 2
  • Laparoscopic approach preferred if no malignancy suspected
  • Demand permanent pathology - frozen sections can miss granulosa cell tumors 2
  • Expect testosterone normalization within days to weeks post-surgery 2

If residual adrenal tissue found:

  • Surgical excision if accessible
  • Consider medical therapy (ketoconazole, metyrapone) if surgery not feasible

Critical Pitfalls to Avoid

  1. Don't assume adrenal incidentalomas explain everything: Your case demonstrates how adrenal findings can mislead from ovarian pathology 5

  2. Don't accept "normal" ultrasound: Bowel gas and operator dependence make ultrasound unreliable - insist on MRI 2

  3. Don't delay if imaging is negative: With testosterone this high and suppressed gonadotropins, proceed to ovarian vein sampling rather than "watch and wait" 1

  4. Don't trust frozen section alone: Permanent pathology with immunohistochemistry (inhibin, calretinin, vimentin) is essential 2

  5. Don't forget long-term surveillance: Granulosa cell tumors can recur years later - you'll need lifelong monitoring with testosterone, inhibin, and imaging 2

Timeline Urgency

  • Hormonal workup: Within 1 week
  • MRI pelvis: Within 2 weeks
  • Specialist consultation (gynecologic oncology or endocrine surgery): Within 2-3 weeks
  • Definitive treatment: Within 4-6 weeks if tumor confirmed

The combination of your complex endocrine history (Cushing's, MACS, primary aldosteronism) with markedly elevated testosterone post-adrenalectomy creates a diagnostic challenge that requires aggressive, systematic evaluation to avoid missing a potentially serious ovarian neoplasm.

Related Questions

What are the differences in symptoms between mild autonomous cortisol secretion (MACS) and Cushing syndrome?
What are the possible causes of elevated total testosterone and elevated free testosterone in a 55-year-old postmenopausal female, 10 weeks after adrenalectomy for a functioning lipid‑poor atypical Cushing's syndrome, Conn's syndrome (primary aldosteronism), and MACS (mild autonomous cortisol secretion)?
What are the risks associated with a total testosterone of 232.86 ng/dL and free testosterone of 2.7 ng/dL in a 55‑year‑old postmenopausal woman who has Cushing’s syndrome, primary aldosteronism (Conn’s syndrome), and had a 6‑cm adrenal tumor surgically removed 10 weeks ago, with normal ovarian imaging?
In a 53-year-old woman whose serum testosterone rose from 47 ng/dL to 390 ng/dL over two months, what is the appropriate evaluation and management?
In a 55-year-old postmenopausal woman 10 weeks after left adrenalectomy for a renal tumor, with markedly elevated total and free testosterone, what could be causing this high testosterone and what diagnostic tests should be performed?
In a patient with bilateral mastectomy, what medication can be used to treat vaginal dryness?
What is dermatomegaly?
How should a 50-year-old male with hypertension, type 2 diabetes, prior myocardial infarction, presenting with acute pleuritic chest pain radiating to the back, sinus bradycardia, left anterior hemiblock, nonspecific ventricular repolarization changes, and a high‑sensitivity troponin T of 22.7 ng/L be managed acutely and investigated for possible acute coronary syndrome?
How should low serum carotene or vitamin A be managed?
What type of vasculitis flares with warm temperatures?
Can oral progesterone be prescribed to a woman with a history of breast cancer who still has her uterus to increase libido and reduce the need for other medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.